Latest News for: biom

Edit

BioMed Realty and Babraham Research Campus Ltd Complete Lease-Up of Newest Building at Babraham Research ...

The Galveston Daily News 24 Feb 2026
CAMBRIDGE, England--(BUSINESS WIRE)--Feb 24, 2026-- ....
Edit

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness ...

Nasdaq Globe Newswire 24 Feb 2026
Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples ... .
Edit

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week,

Hastings Tribune 24 Feb 2026
24, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V.
Edit

BioMed Realty and Babraham Research Campus Ltd Complete Lease-Up of Newest Building at Babraham Research Campus, with TRIMTECH Therapeutics and Tagomics

Pharmiweb 24 Feb 2026
About BioMed Realty. BioMed Realty is the largest private operator of real estate for the life science and technology industries ... BioMed Realty Media Contact. Ivan Alber, Director of Corporate Communications, BioMed Realty.
Edit

Wave of Chinese biotech deals builds as Harbour BioMed, Solstice sign US$1.2 billion pact

South China Morning Post 23 Feb 2026
China’s Harbour BioMed has struck a deal worth more than US$1.2 billion with a clinical-stage ...
Edit

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

Nasdaq Globe Newswire 20 Feb 2026
PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies ...
Edit

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment (Form 6-K) (Psyence Biomedical Ltd)

Public Technologies 20 Feb 2026
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment ... PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical ... About Psyence BioMed.
Edit

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Caledonian Record 19 Feb 2026
19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Mainz Biomed NV)

Public Technologies 19 Feb 2026
MAINZ BIOMED N.V ... MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50 3 ... MAINZ BIOMED N.V ... (1) Grant of restricted shares under Mainz Biomed N.V ... Mainz Biomed NV published this content on February 19, 2026, and is ...
Edit

Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders (Form 6-K) (Psyence Biomedical Ltd)

Public Technologies 19 Feb 2026
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders ... PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing ... About Psyence BioMed.
Edit

Initial Statement of Beneficial Ownership (Form 3) (Mainz Biomed NV)

Public Technologies 19 Feb 2026
) FORM 3 ... Washington, D.C ... OMB Number. 3235-0104 ... 2 ... MAINZ BIOMED N.V ... MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50 4 ... MAINZ BIOMED N.V ... Mainz Biomed NV published this content on February 19, 2026, and is solely responsible for the information contained herein.
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (Mainz Biomed NV)

Public Technologies 19 Feb 2026
MAINZ BIOMED N.V ... Mainz Biomed N.V ... MAINZ BIOMED N.V ... Pharmgenomics GmbH changed its name subsequent to the acquisition to Mainz Biomed Germany GmbH ... The financial statements of Mainz Biomed, N.V ... Mainz Biomed N.V ... 10.4 Mainz Biomed N.V ... Mainz Biomed N.V.
Edit

Advanced Biomed Inc. Announces 1 for 20 Share Consolidation

Nasdaq Globe Newswire 18 Feb 2026
18, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc ... ADVB) (the “Company” or “Advanced Biomed”), a ...
Edit

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

Hastings Tribune 17 Feb 2026
17, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V.
Edit

Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders

Nasdaq Globe Newswire 17 Feb 2026
PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...

Article Search

tools
×
×
×
×